Clinical Trial Update: Combined Injectable Treatment for HIV and OUD [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combined injectable treatment for HIV infection and opioid use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Opioid Use Disorder

Snippet

Sponsor: Rhode Island Hospital | Conditions: Human Immunodeficiency Virus, Opioid Use Disorder | Phase 2 | Status: WITHDRAWN